• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国内分泌外科学会关于继发性和三发性甲状旁腺功能亢进的确定性手术治疗指南。

The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism.

机构信息

Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.

Department of Surgery, Temple University Lewis Katz School of Medicine, Philadelphia, PA.

出版信息

Ann Surg. 2022 Sep 1;276(3):e141-e176. doi: 10.1097/SLA.0000000000005522. Epub 2022 Jul 18.

DOI:10.1097/SLA.0000000000005522
PMID:35848728
Abstract

OBJECTIVE

To develop evidence-based recommendations for safe, effective, and appropriate treatment of secondary (SHPT) and tertiary (THPT) renal hyperparathyroidism.

BACKGROUND

Hyperparathyroidism is common among patients with chronic kidney disease, end-stage kidney disease, and kidney transplant. The surgical management of SHPT and THPT is nuanced and requires a multidisciplinary approach. There are currently no clinical practice guidelines that address the surgical treatment of SHPT and THPT.

METHODS

Medical literature was reviewed from January 1, 1985 to present January 1, 2021 by a panel of 10 experts in SHPT and THPT. Recommendations using the best available evidence was constructed. The American College of Physicians grading system was used to determine levels of evidence. Recommendations were discussed to consensus. The American Association of Endocrine Surgeons membership reviewed and commented on preliminary drafts of the content.

RESULTS

These clinical guidelines present the epidemiology and pathophysiology of SHPT and THPT and provide recommendations for work-up and management of SHPT and THPT for all involved clinicians. It outlines the preoperative, intraoperative, and postoperative management of SHPT and THPT, as well as related definitions, operative techniques, morbidity, and outcomes. Specific topics include Pathogenesis and Epidemiology, Initial Evaluation, Imaging, Preoperative and Perioperative Care, Surgical Planning and Parathyroidectomy, Adjuncts and Approaches, Outcomes, and Reoperation.

CONCLUSIONS

Evidence-based guidelines were created to assist clinicians in the optimal management of secondary and tertiary renal hyperparathyroidism.

摘要

目的

为继发性(SHPT)和 tertiary(THPT)甲状旁腺功能亢进症的安全、有效和适当治疗制定循证推荐。

背景

甲状旁腺功能亢进症在慢性肾脏病、终末期肾脏病和肾移植患者中很常见。SHPT 和 THPT 的手术管理很复杂,需要多学科方法。目前尚无针对 SHPT 和 THPT 手术治疗的临床实践指南。

方法

由 10 名 SHPT 和 THPT 专家组成的小组对 1985 年 1 月 1 日至 2021 年 1 月 1 日的医学文献进行了回顾。使用最佳现有证据构建推荐意见。使用美国医师学院分级系统确定证据水平。讨论推荐意见以达成共识。美国内分泌外科学会会员审查并评论了内容的初稿。

结果

这些临床指南介绍了 SHPT 和 THPT 的流行病学和病理生理学,并为所有相关临床医生提供了 SHPT 和 THPT 的检查和管理建议。它概述了 SHPT 和 THPT 的术前、术中及术后管理,以及相关定义、手术技术、发病率和结果。具体主题包括发病机制和流行病学、初始评估、影像学、术前和围手术期护理、手术计划和甲状旁腺切除术、辅助和方法、结果和再次手术。

结论

制定循证指南是为了帮助临床医生优化继发性和 tertiary 甲状旁腺功能亢进症的管理。

相似文献

1
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism.美国内分泌外科学会关于继发性和三发性甲状旁腺功能亢进的确定性手术治疗指南。
Ann Surg. 2022 Sep 1;276(3):e141-e176. doi: 10.1097/SLA.0000000000005522. Epub 2022 Jul 18.
2
Autotransplant tissue selection criteria with or without stereomicroscopy in parathyroidectomy for treatment of renal hyperparathyroidism.用于治疗肾性甲状旁腺功能亢进的甲状旁腺切除术中使用或不使用体视显微镜的自体移植组织选择标准。
Braz J Otorhinolaryngol. 2014 Jul-Aug;80(4):318-24. doi: 10.1016/j.bjorl.2014.05.012. Epub 2014 Jun 11.
3
Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes.继发性甲状旁腺功能亢进症的治疗与移植后结局的关系。
Transplantation. 2021 Dec 1;105(12):e366-e374. doi: 10.1097/TP.0000000000003653.
4
[Long-term efficacy of parathyroidectomy in secondary and tertiary hyperparathyroidism].甲状旁腺切除术治疗继发性和三发性甲状旁腺功能亢进的长期疗效
Rev Med Inst Mex Seguro Soc. 2019 Dec 30;57(6):371-378.
5
[Treatment of secondary and tertiary hyperparathyroidism--surgical viewpoints].[继发性和三发性甲状旁腺功能亢进的治疗——外科观点]
Chirurg. 1999 Oct;70(10):1089-101. doi: 10.1007/s001040050870.
6
Surgical Management of Secondary and Tertiary Hyperparathyroidism.继发性和三发性甲状旁腺功能亢进的手术治疗。
Surg Clin North Am. 2024 Aug;104(4):825-835. doi: 10.1016/j.suc.2024.02.011. Epub 2024 Mar 21.
7
Medical and surgical treatment for secondary and tertiary hyperparathyroidism.继发性和三发性甲状旁腺功能亢进的内科及外科治疗
Scand J Surg. 2004;93(4):288-97. doi: 10.1177/145749690409300407.
8
Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons' Society of Japan.日本甲状旁腺外科医师协会对继发性和三发性甲状旁腺功能亢进症甲状旁腺切除术的评估。
Ther Apher Dial. 2016 Feb;20(1):6-11. doi: 10.1111/1744-9987.12352.
9
Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.慢性肾脏病继发性甲状旁腺功能亢进的外科治疗——欧洲内分泌外科学会共识报告
Langenbecks Arch Surg. 2015 Dec;400(8):907-27. doi: 10.1007/s00423-015-1344-5. Epub 2015 Oct 2.
10
Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism.改善全球肾脏病预后组织(KDIGO)指南与肾性甲状旁腺功能亢进的甲状旁腺切除术
J Surg Res. 2015 Nov;199(1):115-20. doi: 10.1016/j.jss.2015.04.046. Epub 2015 Apr 18.

引用本文的文献

1
Effect of Parathyroidectomy Timing on the Successful Resolution of Tertiary Hyperparathyroidism in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.甲状旁腺切除术时机对肾移植受者三发性甲状旁腺功能亢进成功缓解的影响:一项系统评价和荟萃分析
J Clin Med. 2025 Aug 22;14(17):5939. doi: 10.3390/jcm14175939.
2
Clinical value of serum iPTH, ALP and serum markers levels in patients with secondary hyperparathyroidism receiving paricalcitol combined with cinacalcet.帕立骨化醇联合西那卡塞治疗继发性甲状旁腺功能亢进患者血清iPTH、ALP及血清标志物水平的临床价值
J Med Biochem. 2025 Jul 4;44(4):759-769. doi: 10.5937/jomb0-55510.
3
Efficacy and safety of thermal ablation for the treatment of recurrent and persistent secondary hyperparathyroidism: a multicenter retrospective study.
热消融治疗复发性和持续性继发性甲状旁腺功能亢进的疗效及安全性:一项多中心回顾性研究
Eur Radiol. 2025 Aug 6. doi: 10.1007/s00330-025-11862-0.
4
Intraoperative parathyroid hormone monitoring to guide surgery in renal hyperparathyroidism (PEREGRINE): a protocol for a randomised multiarm surgical pilot trial.术中甲状旁腺激素监测指导肾性甲状旁腺功能亢进手术(PEREGRINE):一项随机多臂手术试点试验方案
BMJ Open. 2025 Jul 17;15(7):e098860. doi: 10.1136/bmjopen-2025-098860.
5
Chinese expert consensus on endoscopic and robotic parathyroid surgery (version 2025).《中国内镜及机器人甲状旁腺手术专家共识(2025版)》
Surg Endosc. 2025 Jul 14. doi: 10.1007/s00464-025-11866-3.
6
Complications in chemical and thermal ablation of parathyroid lesions: a systematic review and meta-analysis.甲状旁腺病变化学消融和热消融的并发症:系统评价与Meta分析
Eur Radiol. 2025 Jun 7. doi: 10.1007/s00330-025-11739-2.
7
Analysis of Factors Influencing Cardiovascular Events and Mortality in Patients on Dialysis after Parathyroidectomy.甲状旁腺切除术后透析患者心血管事件及死亡率的影响因素分析
Curr Pharm Des. 2025;31(33):2691-2704. doi: 10.2174/0113816128390373250507062606.
8
Efficacy and safety of radiofrequency ablation for hyperparathyroidism: a meta-analysis and systematic review.射频消融治疗甲状旁腺功能亢进症的疗效与安全性:一项荟萃分析与系统评价
Eur Radiol. 2025 Apr 17. doi: 10.1007/s00330-025-11581-6.
9
Spectrum of parathyroid disorders in Pakistan: a review article.巴基斯坦甲状旁腺疾病谱:一篇综述文章
Ann Med Surg (Lond). 2025 Feb 7;87(3):1467-1471. doi: 10.1097/MS9.0000000000003007. eCollection 2025 Mar.
10
The Use of [C]C-Methionine in Diagnostics of Endocrine Disorders with Focus on Pituitary and Parathyroid Glands.[碳-11]蛋氨酸在以垂体和甲状旁腺为重点的内分泌疾病诊断中的应用
Pharmaceuticals (Basel). 2025 Feb 7;18(2):229. doi: 10.3390/ph18020229.